| Rituximab versus cyclophosphamide for ANCA-associated vasculitis JH Stone, PA Merkel, R Spiera, P Seo, CA Langford, GS Hoffman, ... New England Journal of Medicine 363 (3), 221-232, 2010 | 3206 | 2010 |
| Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis ME Wechsler, P Akuthota, D Jayne, P Khoury, A Klion, CA Langford, ... New England Journal of Medicine 376 (20), 1921-1932, 2017 | 953 | 2017 |
| Efficacy of remission-induction regimens for ANCA-associated vasculitis U Specks, PA Merkel, P Seo, R Spiera, CA Langford, GS Hoffman, ... New England Journal of Medicine 369 (5), 417-427, 2013 | 889 | 2013 |
| Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis B Nolle, U Specks, J Lüdemann, MS Rohrbach, RA DeRemee, WL Gross Annals of Internal Medicine 111 (1), 28-40, 1989 | 885 | 1989 |
| ANCA-associated vasculitis AR Kitching, HJ Anders, N Basu, E Brouwer, J Gordon, DR Jayne, ... Nature reviews Disease primers 6 (1), 71, 2020 | 781 | 2020 |
| Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis M Walsh, PA Merkel, CA Peh, WM Szpirt, X Puéchal, S Fujimoto, ... New England Journal of Medicine 382 (7), 622-631, 2020 | 746 | 2020 |
| Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody–associated vasculitis KA Keogh, ME Wylam, JH Stone, U Specks Arthritis & Rheumatism: Official Journal of the American College of …, 2005 | 575 | 2005 |
| Antineutrophil cytoplasmic antibodies GS Hoffman, U Specks Bulletin on the Rheumatic Diseases 47 (6), 5, 1998 | 570 | 1998 |
| A disease‐specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score JH Stone, GS Hoffman, PA Merkel, YI Min, ML Uhlfelder, DB Hellmann, ... Arthritis & Rheumatism 44 (4), 912-920, 2001 | 566 | 2001 |
| Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis RJ Falk, WL Gross, L Guillevin, G Hoffman, DRW Jayne, JC Jennette, ... Annals of the rheumatic diseases 70 (4), 704-704, 2011 | 551 | 2011 |
| Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial KA Keogh, SR Ytterberg, FC Fervenza, KA Carlson, DR Schroeder, ... American journal of respiratory and critical care medicine 173 (2), 180-187, 2006 | 549 | 2006 |
| Eosinophilic granulomatosis with polyangiitis (Churg–Strauss)(EGPA) Consensus Task Force recommendations for evaluation and management M Groh, C Pagnoux, C Baldini, E Bel, P Bottero, V Cottin, K Dalhoff, ... European journal of internal medicine 26 (7), 545-553, 2015 | 537 | 2015 |
| Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis X Bossuyt, JW Cohen Tervaert, Y Arimura, D Blockmans, ... Nature Reviews Rheumatology 13 (11), 683-692, 2017 | 436 | 2017 |
| Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis JP Utz, AH Limper, S Kalra, U Specks, JP Scott, Z Vuk-Pavlovic, ... Chest 124 (1), 177-185, 2003 | 429 | 2003 |
| Response of Wegener's granulomatosis to anti‐CD20 chimeric monoclonal antibody therapy U Specks, FC Fervenza, TJ McDonald, MCE Hogan Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 424 | 2001 |
| Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists KA Keogh, U Specks The American journal of medicine 115 (4), 284-290, 2003 | 384 | 2003 |
| Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten‐year experience at a single center R Cartin‐Ceba, JM Golbin, KA Keogh, T Peikert, M Sánchez‐Menéndez, ... Arthritis & Rheumatism 64 (11), 3770-3778, 2012 | 379 | 2012 |
| ANCA are detectable in nearly all patients with active severe Wegener’s granulomatosis JD Finkielman, AS Lee, AM Hummel, MA Viss, GL Jacob, HA Homburger, ... The American journal of medicine 120 (7), 643. e9-643. e14, 2007 | 372 | 2007 |
| Rituximab treatment of idiopathic membranous nephropathy FC Fervenza, FG Cosio, SB Erickson, U Specks, AM Herzenberg, ... Kidney international 73 (1), 117-125, 2008 | 358 | 2008 |
| Rituximab therapy in idiopathic membranous nephropathy: a 2-year study FC Fervenza, RS Abraham, SB Erickson, MV Irazabal, A Eirin, U Specks, ... Clinical journal of the American Society of Nephrology 5 (12), 2188-2198, 2010 | 356 | 2010 |